On the chart you can see the default numbers in dynamics for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ). Companys revenue shows the average of 3097.766 M which is 0.492 % gowth. The average gross profit for the whole period is 1080.953 M which is 0.530 %. The average gross profit ratio is 0.354 %. The net income growth for the company last year performance is -2.077 % which equals 0.753 % % on average for the whole company history.,
Diving into the fiscal trajectory of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.077. In the realm of current assets, 002399.SZ clocks in at 10603.905 in the reporting currency. A significant portion of these assets, precisely 2265.826, is held in cash and short-term investments. This segment shows a change of -0.343% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 2514.928, if any, in the reporting currency. This indicates a difference of 118.222% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 1810.021 in the reporting currency. This figure signifies a year_over_year change of -0.139%. Shareholder value, as depicted by the total shareholder equity, is valued at 11913.149 in the reporting currency. The year over year change in this aspect is -0.032%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 1528.563, with an inventory valuation of 6654.11, and goodwill valued at 2322.38, if any. The total intangible assets, if present, are valued at 493.22. Account payables and short-term debt are 302.22 and 3662.38, respectively. The total debt is 5562.82, with a net debt of 3711.17. Other current liabilities amount to 655.41, adding to the total liabilities of 7184.2. Lastly, the referred stock is valued at 0, if it exists.
The financial landscape of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 1.027. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to 1141196677.000 in the reporting currency. This is a shift of 3.568 from the previous year. In the same period, the company recorded 384.67, -0.13, and -730.86, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -146.73 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -325.38, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s revenue saw a change of -0.243% compared with the previous period. The gross profit of 002399.SZ is reported to be 1675.41. The company's operating expenses are 1935.36, showing a change of 59.702% from the last year. The expenses for depreciation and amortization are 384.67, which is a 0.250% change from the last accounting period. Operating expenses are reported to be 1935.36, which shows a 59.702% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -1.229% year-over-year growth. The operating income is -259.95, which shows a -1.229% change when compared to the previous year. The change in the net income is -2.077%. The net income for the last year was -783.26.
